(Q52845203)

8 May 2018

title

Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1. (English)

1 reference

8 May 2018

1 reference

Simon R Carding

10

0 references

Mark D. Farrar

object named as

Mark D Farrar

3

0 references

author name string

Zaed Z R Hamady

1

1 reference

8 May 2018

Nigel Scott

2

1 reference

8 May 2018

Meenu Wadhwa

4

1 reference

8 May 2018

Paula Dilger

5

1 reference

8 May 2018

Terence R Whitehead

6

1 reference

8 May 2018

Robin Thorpe

7

1 reference

8 May 2018

Keith T Holland

8

1 reference

8 May 2018

J Peter A Lodge

9

1 reference

8 May 2018

publication date

17 December 2010

1 reference

8 May 2018

Inflammatory Bowel Diseases

published in

1 reference

8 May 2018

volume

17

1 reference

8 May 2018

issue

9

1 reference

8 May 2018

page(s)

1925-1935

1 reference

8 May 2018

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

cites work

1 reference

Inflammatory bowel disease: cause and immunobiology

21 January 2018

1 reference

Role of cytokines in inflammatory bowel disease

21 January 2018

1 reference

TGF-beta1 and Smad7 in the regulation of IBD.

21 January 2018

1 reference

Regulation of intestinal epithelial cell growth by transforming growth factor type beta

21 January 2018

1 reference

Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation

21 January 2018

1 reference

Regulation of transforming growth factor expression in rat intestinal epithelial cell lines

21 January 2018

1 reference

Smad7 in TGF-beta-mediated negative regulation of gut inflammation

21 January 2018

1 reference

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

21 January 2018

1 reference

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

21 January 2018

1 reference

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

21 January 2018

1 reference

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa

21 January 2018

1 reference

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

TGF-beta as a T cell regulator in colitis and colon cancer.

21 January 2018

1 reference

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution

21 January 2018

1 reference

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

21 January 2018

1 reference

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

21 January 2018

1 reference

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

Physiology and genetics of xylan degradation by gastrointestinal tract bacteria

21 January 2018

1 reference

Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins

21 January 2018

1 reference

Efficacy of repifermin (keratinocyte growth factor-2) against abnormalities in gastrointestinal mucosal transport in a murine model of colitis

21 January 2018

1 reference

Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity

21 January 2018

1 reference

Purification and initial characterization of a type beta transforming growth factor from human placenta

21 January 2018

1 reference

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

21 January 2018

1 reference

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

21 January 2018

1 reference

Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.

21 January 2018

1 reference

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

21 January 2018

1 reference

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

21 January 2018

1 reference

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

21 January 2018

1 reference

Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1.

21 January 2018

1 reference

Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice

21 January 2018

1 reference

Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis.

21 January 2018

1 reference

Trefoil factors: initiators of mucosal healing

21 January 2018

1 reference

Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells

21 January 2018

1 reference

Advances in the manufacture, purification and applications of xylo-oligosaccharides as food additives and nutraceuticals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21565

1 reference

8 May 2018

1 reference

8 May 2018